NEEDLE AND SYRINGE PROGRAMMES IN THE UK Jamie Bridge, NNEF Chair

Slides:

Advertisements

Similar presentations

Injecting drug use and infections. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian Hope, Dr Fortune Ncube.

Advertisements

NICE Guidance on Needle and Syringe Programmes: Providing Injecting Equipment to People who Inject Drugs. Professor Mike Kelly, PhD, FFPH. Director, The.

Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.

Needle exchange: an NTA perspective 1 July 2009 Hugo Luck.

Graham Parsons. Pharmacist with Special Interest (PhwSI) NHS Plymouth.

Pharmacy: looking to the future Kevin Ratcliffe Consultant Pharmacist.

NSP PROVISION WITHIN SPECIALIST DRUG SERVICES. What is it? Integral part of Harm Reduction in nx provision Integral part of Harm Reduction in nx provision.

Delivering effective needle and syringe programmes: Implementing NICE guidance Working with Local Authorities: Planning Applications for Needle Exchanges.

Needle and syringe programmes Implementing NICE guidance 2009 NICE public health guidance 18.

Glasgow Involvement Group Views from injecting drugs users in Glasgow Pathways to Treatment and Care Conference Stirling Royal Infirmary 30 th September.

Robin Pollard Operations Coordinator Youth RISE.

Turning the tide: Not without prisons! Promoting comprehensive national HIV responses.

Waltham Forest Substance Misuse Needs Assessment and Treatment System Review Eric Ayesu-Boapeah – Senior Public Health Strategist Trevor Givans – Substance.

Mental Health, Drugs and Regions Division: Local Government Drug Issues Forum 11 August 2011.

MDM Harm Reduction (needle exchange) program in Kabul-Afghanistan.

Substance misuse sector Or Sexual health sector? Is this a drug problem Or A sex problem?

Updating the NICE NSP Guidance Chris Carmona, Public Health Analyst Centre for Public Health.

ENGAGING WITH LAW ENFORCEMENT: PREVENTION, MONITORING AND RESPONSE Basha Silverman, Brandywine Counseling & Community Services.

Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.

Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.

Presentation ‘Developing positive working relationships between Health and Law Enforcement Agencies’

HIV/AIDS Asia Regional Project (HAARP) Training Program for Police Effective Strategies for reducing the spread of HIV/AIDS among and from Injecting Drug.

Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.

Module 2 Harm Reduction and the Needle and Syringe Program.

Existing services and the wraparound challenges Biba Brand West of Scotland Regional Manager.

HIV and drug prevention in Estonia Harm reduction services

NACO and NACP. Response of Govt to HIV National AIDS Control Programme (NACP) under Ministry of Health & Family Welfare in 1992 NACP I (1992 – 1999) NACP.

Treatment of drug addiction in prisons

Louisa Degenhardt 1, Bradley Mathers 1, Peter Vickerman 2, Tim Rhodes 3, Carl Latkin 4 and Matt Hickman 5 1.National Drug and Alcohol Research Centre,

Harm Reduction.

HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Signe ROTBERGA UNODC, Baltic States 5 November.

RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.

HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.

Young People’s Drug and Alcohol Specialist Treatment Service for Wiltshire.

All Change! Infections, injecting drug use and harm reduction. Vivian Hope IDU Team, HIV & STI Department, Health Protection Services – Colindale Dr Vivian.

Injection drug use among men who have sex with men (MSM) Dr Adam Bourne Sigma Research London School of Hygiene & Tropical Medicine

Police leadership in public health: what do we get? G e o f f r e y M O N A G H A N Police Leadership in Public Health What Do We Get? Workshop December.

If I ruled the world… Presentation to Prisons and Beyond NOMS Prison Drug Strategy Unit, in association with the Federation of Drug & Alcohol Professionals.

Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.

Network of Low-Threshold Centres as a Response to Concentrated HIV Epidemic among IDUs in Latvia.

Police DRUG POLICY And PROGRAMS. Harm Minimisation Supply Reduction Demand Reduction Harm Reduction.

Network Update Cathy Young Managed Care Network Manager 16 th June 2011.

Commissioning Update – Specifications, Performance and Funding Ben Seale January 2012.

Salford’s Alcohol Strategy Background Salford’s Drug and Alcohol Strategy Safe. Sensible. Social. : next steps in the national alcohol.

1 Needle Exchange Provision in Scotland Selected results from the National Needle Exchange Survey Dawn Griesbach Griesbach & Associates 28 February 2007.

Testing, Treatment, Care and Support Revised Actions for Phase II.

Keeping up with the epidemic Programme success leaves us with new challenges: An evaluation of programmes for injecting sex workers.

School of Public Health and Community Medicine How policies and repressive law- enforcement fuel the HIV epidemic among people who inject drugs Professor.

+ Science & politics – synergy or conflict The drive to time-limit OST – is it austerity or ideology ? Is it good science and good practice ? Annette Dale-Perera.

Global Fund in Estonia Kaja Põlluste, MD, MPH Department of Public Health & Department of Internal Diseases University of Tartu Estonia.

Users’ Experience of Injecting Problems and Services Glenda Daniels – OUT Service Coordinator

BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.

Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.

1 NTA More treatment, better treatment, fairer treatment National injecting conference Annette Dale-Perera Director of Quality.

1 John Campbell.  Poor UK survey Data  Small area or location studies  Glasgow accurate NEO data.

Young Person’s substance misuse service in Hampshire Julie Poling – Team Leader.

Washington, D.C. Nov. 3-7, 2007 Where do all the syringes come from? Pharmacy contribution to needle and syringe distribution in Hanoi, Vietnam Christopher.

Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,

NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.

Needle and syringe exchange and working with injecting drug users

Addressing Drug Use Together Through a Health Based Approach:

Reitox National Focal Point National Bureau for Drug Prevention

Greater Manchester Suicide Prevention

Josie Smith Research Scientist, NPHS

NPS current health-related practices and challenges in responding to use and harms in Europe Findings from a multi-method study Alessandro Pirona Lisbon.

1 Source Heor, 2 University of Bristol, 3 Bristol Drugs Project, UK

STIs among people who use drugs

Blood borne viral hepatitis action in Wales

Mission: To reduce morbidity associated with the prevalence of TB and HIV among at-risk drug users and their contacts.

Human Dignity and Harm Reduction

Presentation transcript:

NEEDLE AND SYRINGE PROGRAMMES IN THE UK Jamie Bridge, NNEF Chair

First UK NSPs in 1980s ACMD (1988): “The spread of HIV is a greater danger to individual and public health than drug misuse” Wealth of international evidence: –Impacts on HIV, risk behaviour –Increases drug treatment uptake –Cost effective –“No convincing evidence” of unintended consequences

More than just needles…

NTA Needle Exchange Audit Average DAT in 2006 = –2.4 specialist NSPs –11 pharmacy-based NSPs “Mixed economy”: ~50% DATs did not provide BBV testing ~ 40% did not provide immunisations ~33% did not provide safer injecting advice

Issues to Discuss Impacts of budget cuts on NSP / HR Impacts of localisation Over-reliance on pharmacy exchanges Complacency among decision makers Performance and Image Enhancing Drugs Mephedrone injecting Reduced staff training and specialism